The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells

Journal of Cellular Physiology

Volumn 216, Issue 1, 2008, Pages 135-143

  Murayama, Yoko ^a,b   Shinomura, Yasuhisa ^c   Oritani, Kenji ^a   Miyagawa, Jun Ichiro ^d   Yoshida, Hitoshi ^a   Nishida, Makoto ^e   Katsube, Fumie ^a   Shiraga, Masamichi ^a   Miyazaki, Tamana ^a   Nakamoto, Taisei ^a   Tsutsui, Shusaku ^a   Tamura, Shinji ^a,g   Higashiyama, Shigeki ^f   Shimomura, Iichirou ^a   Hayashi, Norio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Itami City Hospital   (Japan)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g Minoh City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD9 ANTIGEN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ALB6; TETRASPANIN; ANTIBODY; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MULTIPROTEIN COMPLEX; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; ATTENUATION; CANCER CELL; CELL CONTACT; CELL SURFACE; CHO CELL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; LIVER CELL CARCINOMA; MODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; ANIMAL; GENETICS; HAMSTER; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CRICETULUS GRISEUS;

ANIMALS; ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD29; CELL LINE, TUMOR; CRICETINAE; HUMANS; MEMBRANE GLYCOPROTEINS; MULTIPROTEIN COMPLEXES; NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 44449179354     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21384     Document Type: Article

References (51)

1. Anzai N, Lee Y, Youn BS, Fukuda S, Kim YJ, Mantel C, Akashi M, Broxmeyer HE. 2002. C-kit associated with the transmembrane 4 superfamily proteins constitutes a functionally distinct subunit in human hematopoietic progenitors. Blood 99:4413-4421.
2. Aoyama K, Oritani K, Yokota T, Ishikawa J, Nishiura T, Miyake K, Kanakura Y, Tomiyama Y, Kincade PW, Matsuzawa Y. 1999. Stromal cell CD9 regulates differentiation of hematopoietic stem/progenitor cells. Blood 93:2586-2594.
3. Baudoux B, Castanares-Zapatero D, Leclercq-Smekens M, Berna N, Poumay Y. 2000. The tetraspanin CD9 associates with the integrin alpha6beta4 in cultured human epidermal keratinocytes and is involved in cell motility. Eur J Cell Biol 79:41-51.
4. Berditchevski F. 2001. Complexes of tetraspanins with integrins: More than meets the eye. J Cell Sci 14:4143-4151.
5. Berditchevski F, Odintsovam E. 1999. Characterization of integrin-tetraspanin adhesion complexes: Role of tetraspanins in integrin signaling. J Cell Biol 146:477-492.
6. Berditchevski F, Zutter MM, Hemler ME. 1996. Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol Biol Cell 7:193-207.
7. Boucheix C, Rubinstein E. 2001. Tetraspanins. Cell Mol Life Sci 58:1189-1205.
8. Boucheix C, Soria C, Mirshahi M, Soria J, Perrot JY, Fournier N, Billard M, Rosenfeld C. 1983. Characteristics of platelet aggregation induced by the monoclonal antibody ALB6 (acute lymphoblastic leukemia antigen p 24). Inhibition of aggregation by ALB6 Fab. FEBS Lett 16:289-295.
9. Boucheix C, Benoit P, Frachet P, Billard M, Worthington RE, Gagnon J, Uzan G. 1991. Molecular cloning of the CD9 antigen. A new family of cell surface proteins. J Biol Chem 266:117-122.
10. Cajot JF, Sordat I, Silvestre T, Sordat B. 1997. Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res 57:2593-2597.
11. Duffield A, Kamsteeg EJ. Brown AN, Pagel P, Caplan MJ. 2003. The tetraspanin CD63 enhances the internalization of the H, K-ATPase beta-subunit. Proc Nat Acad Sci 100:15560-15565.
12. Gotoh N, Tojo A, Hino M, Yazaki Y, Shibuya M. 1992. A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor. Biochem Biophys Res Commun 186:768-774.
13. Gutierrez-Lopez MD, Ovalle S, Yanez-Mo M, Sanchez-Sanchez N, Rubinstein E, Olmo N, Lizarbe MA, Sanchez-Madrid F, Cabanas C. 2003. A functionally relevant conformational epitope on the CD9 tetraspanin depends on the association with activated beta1 integrin. J Biol Chem 278:208-218.
14. He B, Liu L, Cook GA, Grgurevich S, Jennings LK, Zhang XA. 2005. Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion. J Biol Chem 280:3346-3354.
15. Hemler ME. 2003. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol 19:397-422.
16. Higashiyama S, Iwamoto R, Goishi K, Raab G, Taniguchi N, Klagsbrun M, Mekada E. 1995. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol 128:929-938.
17. Higashiyama M, Doi O, Kodama K, Yokouchi H, Adachi M, Huang CL, Taki T, Kasugai T, Ishiguro S, Nakamori S, Miyake M. 1997. Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis. Int J Cancer 74:205-211.
18. Huang CI, Kohno N, Ogawa E, Adachi M, Taki T, Miyake M. 1998. Correlation of reduction in MRP-1/CD9 and KA11/CD82 expression with recurrences in breast cancer patients. Am J Pathol 153:973-983.
19. Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyake M. 1993. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 177:1231-1237.
20. Inui S, Higashiyama S, Hashimoto K, Higashiyama M, Yoshikawa K, Taniguchi N. 1997. Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth. J Cell Physiol 171:291-298.
21. Jones PH, Bishop LA, Watt FM. 1996. Functional significance of CD9 association with beta 1 integrins in human epidermal keratinocytes. Cell Adhes Commun 4:297-305.
22. Kaji K, Takeshita S, Miyake K, Takai T, Kudo A. 2001. Functional association of CD9 with the Fc gamma receptors in macrophages. J Immunol 166:3256-3265.
23. Ko EM, Lee IY, Cheon IS, Kim J, Choi JS, Hwang JY, Cho JS, Lee DH, Kang D, Kim SH, ChoeJ. 2006. Monoclonal antibody to CD9 inhibits platelet-induced human endothelial cell proliferation. Mol Cells 22:70-77.
24. Larjava H, Peltonen J, Akiyama SK, Yamada SS, Gralnik HR, Uitto J, Yamada KM. 1990. Novel function for beta 1 integrins in keratinocyte cell-cell interactions. J Cell Biol 110:803-815.
25. Le Naour F, Charrin S, Labas V, Le Caer JP, Boucheix C, Rubinstein E. 2004. Tetraspanins connect several types of Ig proteins: IgM is a novel component of the tetraspanin web on B-lymphoid cells. Cancer Immunol Immunother 53:148-152.
26. Longo N, Yanez-Mo M, Mittelbrunn M, de la Rosa G, Munoz ML, Sanchez-Madrid F, Sanchez-Mateos P. 2001. Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells. Blood 98:3717-3726.
27. Maecker HT, Todd SC, Levy S. 1997. The tetraspanin superfamily: Molecular facilitators. FASEB J 1:428-442.
28. Mainiero F, Murgia C, Wary KK, Curatola AM, Pepe A, Blumemberg M, Westwic kJK, Der CJ, Giancotti FG. 1997. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J 16:2365-2375.
29. Miyado K, Yamada G, Yamada S, Hasuwa H, Nakamura Y, Ryu F, Suzuki K, Kosai K, Inoue K, Ogura A, Okabe M, Mekada E. 2000. Requirement of CD9 on the egg plasma membrane for fertilization. Science 287:321-324.
30. Miyake M, Nakano K, Itoi SI, Koh T, Taki T. 1996. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res 56:1244-1249.
31. Moghal N, Sternberg PW. 1999. Multiple positive and negative regulators of signaling by the EGF-receptor. Curr Opin Cell Biol 11:190-196.
32. Mori M, Mimori K, Shiraishi T, Haraguchi M, Ueo H, Barnard GF, Akiyoshi T. 1998. Motility related protein 1 (MRP1/CD9) expression in colon cancer. Clin Cancer Res 4:1507-1510.
33. Moro L, Venturino M, Bozzo C, Silengo L, Altruda F, Beguinot L, Tarone G, Defilippi P. 1998. Integrins induce activation of EGF receptor: Role in MAP kinase induction and adhesion-dependent cell survival. EMBO J 17:6622-6632.
34. Murayama Y, Miyagawa J, Shinomura Y, Kanayama S, Isozaki K, Yamamori K, Mizuno H, Ishiguro S, Kiyohara T, Miyazaki Y, Taniguchi N, Higashiyama S, Matsuzawa Y. 2002. Significance of the association between heparin-binding epidermal growth factor-like growth factor and CD9 in human gastric cancer. Int J Cancer 98:505-513.
35. Murayama Y, Miyagawa J, Oritani K, Yoshida H, Yamamoto K, Kishida O, Miyazaki T, Tsutsui S, Kiyohara T, Miyazaki Y, Higashiyama S, Matsuzawa Y, Shinomura Y. 2004. CD9-mediated activation of the p46 Shc isoform leads to apoptosis in cancer cells. J Cell Sci 117:3379-3388.
36. Nakamura K, Iwamoto R, Mekada E. 1995. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites. J Cell Biol 129:1691-1705.
37. Odintsova E, Sugiura T, Berditchevski F. 2000. Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KA1-1. Curr Biol 16:1009-1012.
38. Oritani K, Wu X, Medina K, Hudson J, Miyake K, Gimble JM, Burstein SA, Kincade PW. 1996. Antibody ligation of CD9 modifies production of myeloid cells in long-term cultures. Blood 87:2252-2261.
39. Penas PF, Garcia-Diez A, Sanchez-Madrid F, Yanez-Mo M. 1998. Differential expression of activation epitopes of beta1 integrins in psoriasis and normal skin. J Invest Dermatol 111:19-24.
40. Pronk GJ, de Vries-Smits AM, Buday L, Downward J, Maassen JA, Medema RH, Bos JL 1994. Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras. Mol Cell Biol 14:1575-1581.
41. Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PG, et al. 1992. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360:689-692.
42. Rubinstein E, Le Naour F, Lagaudriere-Gesbert C, Billard M, Conjeaud H, Boucheix C. 1996. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol 26:2657-2665.
43. Shaw AR, Domanska A, Mak A, Ginlchrist A, Dobler K, Visser L, Poppema S, Fliegel L, Letarte M, Willett BJ. 1995. Ectopic expression of human and feline CD9 in a human B cell line confers beta 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation. J Biol Chem 270:24092-24099.
44. Shi W, Fan H, Shum L, Derynck R. 2000. The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation. J Cell Biol 148:591-602.
45. Sho M, Adachi M, Taki T, Hashida H, Konishi T, Huang CL, Ikeda N, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M. 1998. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int J Cancer 79:509-516.
46. Symington BE, Takada Y, Carter WG. 1993. Interaction of integrins alpha 3 beta 1 and alpha 2 beta 1: Potential role in keratinocyte intercellular adhesion. J Cell Biol 120:523-535.
47. Uchida S, Shimada Y, Watanabe G, Li ZG, Hong T, Miyake M, Imamura M. 1999. Motility-related protein (MRP-1/CD9) and KA11/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 79:1168-1173.
48. Wu H, Peng L, Li J, Wu W, Hou Q, Liu H, Wang M. 1999. Reversible exposure of human platelet fibrinogen receptors by antiplatelet tetraspanin monoclonal antibodies via induction of a conformational change in membrane glycoprotein IIb/IIIa complex. Thromb Res 95:245-253.
49. Yáñez-Mó M, Alfranca A, Cabañas C, Marazuela M, Tejedor R, Ursa A, Ashman LK, De Landázuri MO, Sanchez-Madrid F. 1998. Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta 1 integrin localized at endothelial lateral junctions. J Cell Biol 14:791-804.
50. Yu X, Miyammoto S, Mekada E. 2000. Integrin alpha 2 beta 1-dependent EGF receptor activation at cell-cell contact sites. J Cell Sci 113:2139-2147.
51. Zhang XA, Bontrager AL, Hemler ME. 2001. Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta (1) integrins. J Biol Chem 276:25005-25013.